August 2022 PMID 35843362

Diminished T-cell immune responses to SARS-CoV-2 omicron variant after BNT162b2 vaccination.

Stanley C Jordan, Bong-Ha Shin, Edgar Rodriguez, Ashley Vo, NorikoAmmerman, Ruan Zhang

Mentions

3
Peak: 2 in Sep 2025
across 2 sources since Jul 2022

Extended reach

31,709
potential audience

Total likes

2,950

Video views

31,349

Mentions per month

Jul 2022 – Sep 2025

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reflect a positive reception of the publication, with users emphasizing that T-cell responses may still provide protection despite reduced antibody effectiveness. Words like 'important,' 'noteworthy,' and 'implications' show deep engagement with the research's significance for the ongoing pandemic response.

AgreementModerate agreement

Most discussions acknowledge the findings regarding diminished antibody responses but emphasize the significance of T-cell immunity, showing general agreement on the study's implications.

InterestHigh interest

Posts display high interest in the research's relevance to vaccine efficacy and future COVID-19 strategies.

EngagementModerate engagement

Participants refer to specific aspects such as T-cell responses and vaccine implications, indicating meaningful engagement.

ImpactModerate impact

The discussions suggest a moderate impact by highlighting potential influences on vaccine development and booster strategies.

Abstract in brief

  • The study investigates how the immune system, specifically T-cell responses, reacts to the Omicron variant of SARS-CoV-2 after people receive the BNT162b2 (Pfizer) COVID-19 vaccine.
  • Results show that while antibody responses to Omicron are reduced, T-cell responses remain relatively strong, which may help in providing protection.
  • This suggests that T-cell immunity could play an important role in preventing severe illness from Omicron, even if antibody effectiveness decreases.]

Top posts

Most liked on X and Bluesky
Transplant Immunotherapy Program Los Angeles
@TIPLosAngeles · X

Read Dr Jordan’s publication in #Immunology Letters, Diminished T-cell Immune Responses to #SARS-CoV-2 #Omicron Variant after #BNT162b2 Vaccination

Jul 15, 2022 · 361 followers View post →

All mentions

Transplant Immunotherapy Program Los Angeles
@TIPLosAngeles · X

Read Dr Jordan’s publication in #Immunology Letters, Diminished T-cell Immune Responses to #SARS-CoV-2 #Omicron Variant after #BNT162b2 Vaccination

Jul 15, 2022 · 361 followers View post →